Davanagere Cancer Center Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 7 Year, 22 Days
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2021)
- Profit -166.59%
(FY 2021)
- Ebitda -195.83%
(FY 2021)
- Net Worth -195.43%
(FY 2021)
- Total Assets 4537.89%
(FY 2021)
About Davanagere Cancer Center
The Corporate was formerly known as Warangal Cancer Center Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kiran Vakkalanka, Chinnababu Sunkavalli, and Hemanth Vudayaraju serve as directors at the Company.
- CIN/LLPIN
U85200TG2017PTC120907
- Company No.
120907
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Nov 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Davanagere Cancer Center?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiran Vakkalanka  | Director | 30-Nov-2017 | Current |
| Chinnababu Sunkavalli | Director | 30-Nov-2017 | Current |
| Hemanth Vudayaraju | Director | 30-Nov-2017 | Current |
Financial Performance of Davanagere Cancer Center.
Davanagere Cancer Center Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 166.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 195.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Davanagere Cancer Center?
In 2021, Davanagere Cancer Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Excel Soft Services (India) Private LimitedActive 19 years 6 monthsChinnababu Sunkavalli is a mutual person
Sadguruvijaya Hospitals Private LimitedActive 14 years 1 monthHemanth Vudayaraju is a mutual person
- Bg-Radio Nuclear Pet Imaging LlpActive 1 year 3 months
Kiran Vakkalanka and Chinnababu Sunkavalli are mutual person
- Bridge Gap Lifesciences Private LimitedActive 10 years 10 months
Kiran Vakkalanka and Chinnababu Sunkavalli are mutual person
- Khammam Cancer Hospital Private LimitedActive 7 years 1 month
Kiran Vakkalanka and Chinnababu Sunkavalli are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Davanagere Cancer Center?
Unlock and access historical data on people associated with Davanagere Cancer Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Davanagere Cancer Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Davanagere Cancer Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
